Fig. 3From: Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysisThe forest plot of studies reporting 1-month mortality. Studies were ranked according to their effect sizes. #Ampicillin–sulbactam was used in non-polymyxins group. *Trimethoprim-sulfamethoxazole was used in non-polymyxins groupBack to article page